A. History of recent electronic cigarette use
Discussion
This patient reports inhaling a novel electronic cigarette
(e-cigarette) flavor just hours prior to onset of her symptoms but has
been using e-cigarettes with nicotine and intermittently combined with
THC for the past 6 months. She admitted to using combustible cigarettes
when questioned about smoking but was not forthcoming with her use of
e-cigarettes, highlighting the difficulty in diagnosing and determining
underlying etiology in these patients. The bilateral bibasilar opacities
on chest imaging and diffuse ground-glass appearance on chest CT are
consistent with inhalational injuries seen in other cases of ARDS
secondary to e-cigarette use.1
E-cigarettes are inhalational devices that produce aerosols by
heating a liquid that can contain a multitude of chemicals, including
flavoring, nicotine, THC or other additives. Initially marketed as a
safer alternative to combustible cigarettes, e-cigarettes have been
linked to a heterogeneous collection of pneumonitis patterns with
manifestations of lung injury depending on the amount and
characteristics of compounds inhaled. Initial symptoms often include
cough, shortness of breath, and fever but more severe presentations such
as hemoptysis or acute respiratory failure have been reported.2
While the underlying mechanism of lung injury is unknown, there is
substantial evidence that e-cigarette aerosols can induce acute
endothelial cell dysfunction and promote formation of reactive oxygen
species/oxidative stress, although the long term effects of e-cigarettes
remain unknown.3 E-cigarettes have been shown to contain
toxic compounds such as nicotine, carbonyls, volatile organic compounds
(such as benzene and toluene), and bacterial endotoxins and fungal
glucans.4 No universal treatment plans have been established, but steroids have been shown to be effective in some patients.5
References
-
Henry TS, Kanne JP, Kligerman SJ. Imaging of Vaping-Associated Lung
Disease. N Engl J Med. [Epub ahead of print on 2019 Sep 6]. doi:
10.1056/NEJMc1911995.
-
Layden JE, Ghinai I, Pray I, et al. Pulmonary Illness Related to
E-Cigarette Use in Illinois and Wisconsin - Preliminary Report. N Engl J
Med. [Epub ahead of print on 2019 Sep 6]. doi: 10.1056/NEJMoa1911614.
-
Eaton DL, Kwan LY, Stratton K, eds. Public Health Consequences of
E-Cigarettes. Washington (DC): National Academies Press; 2018:1-16.
-
Christiani DC. Vaping-Induced Lung Injury. N Engl J Med. [Epub ahead of print on 2019 Sep 6]. doi: 10.1056/NEJMe1912032.
-
Schier JG, Meiman JG, Layden J, et al. Severe Pulmonary Disease
Associated with Electronic-Cigarette-Product Use - Interim Guidance.
MMWR Morb Mortal Wkly Rep 2019;68:787-90.